Skip to main content
Clinical Trials/IRCT201504042639N15
IRCT201504042639N15
Completed
Phase 2

Evaluation of efficacy of topiramate and topiramate with supplement ferrous sulfate on monthly frequency, severity, and disability score of migraine headaches in 5-15 year old migraineur children without iron deficiency

Research Deputy of Shahid Sadoughi University of Medical Sciences , Yazd, Iran0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Migraine.
Sponsor
Research Deputy of Shahid Sadoughi University of Medical Sciences , Yazd, Iran
Enrollment
60
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Research Deputy of Shahid Sadoughi University of Medical Sciences , Yazd, Iran

Eligibility Criteria

Inclusion Criteria

  • Children aged 5\-15 years , Having migraine headache based on International Headache Society Criteria , Having one or more headache attack per week , Having moderate or severe headache disability , Having no iron deficiency (serum hemoglobin, iron and ferritin levels in normal limits) , Have not received iron combinations within the past two months , Not used any migraine preventive therapy
  • Exclusion criteria: Secondary headaches such as epilepsy or other neurologic disorders, Irregular drugs usage, Discontinuation of iron usage for more than one week

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials